As the COVID-19 pandemic swells, experts around the globe are working to determine which existing medicines might help patients experiencing severe illness. Malaria drug chloroquine has gotten a lot of the attention, but now a team suggests a Roche stroke drug is worth exploring. In an article in the Journal of Trauma and Acute Care Surgery, authors wrote that tissue plasminogen activator, or… Read More »
By Michael Le Page We might soon have a home test for covid-19 ED JONES/AFP via Getty Images The UK has ordered 3.5 million antibody tests designed to reveal if people have been infected with the coronavirus. The UK’s prime minister Boris Johnson, who today announced he himself has tested positive for the virus, has… Read More »
“Act fast and do whatever it takes,” insists the second half of the title of a new eBook with contributions from forty leading economists from around the world. The first half of the title is, Mitigating the COVID Economic Crisis. The book is discussed in a World Economic Forum essay discussing the economists’ consensus to “act… Read More »
In a few short weeks, the novel coronavirus pandemic has upturned countries around the world, presenting new and complex workplace challenges. That shift is also true for drugmakers working to combat COVID-19. For New York-based Regeneron––at the forefront of the COVID-19 hunt––those challenges are unprecedented and extraordinary, but it’s still mostly business as usual. After… Read More »
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring. As the coronoavirus pandemic spreads and hunkered-down Americans wonder when and how they’ll get back on the job, a Harvard epidemiologist… Read More »